Indeed, a growing number of interactors has been recently identified and proposed to promote GBM malignancy through their co-operation with PrPC, also suggesting that PrPC itself could become a relevant target for therapies specifically directed against the CSC subpopulation [47] (Figure 1). Here, PRNP is linked to glioblastoma.